Serafín Morales
Hospital Universitari Arnau de Vilanova(ES)Hospital Arnau de Vilanova(ES)Complejo Asistencial Sótero del Río(CL)Universidad Quetzalcóatl(MX)GEICAM – Spanish Breast Cancer Group(ES)Manomet Conservation Sciences(US)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Lung Cancer Research Studies
Most-Cited Works
- → Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer(2023)619 cited
- → Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial(2017)580 cited
- → Phase II Study of Efficacy, Safety, and Pharmacokinetics of Trastuzumab Monotherapy Administered on a 3-Weekly Schedule(2005)425 cited
- → HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial(2017)336 cited
- → Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial(2016)289 cited
- →